Associations between HIV infection status, psychosocial factors, and adjuvant endocrine therapy adherence among South African women with early-stage breast cancer

被引：0
|
作者：
O'Neil, Daniel
Blanchard, Charmaine
Ream, Molly
Mmoledi, Keletso
Mkwanazi, Nontlantla
Shandukani, Victor
Ruff, Paul
Antoni, Michael
Joffe, Maureen
机构：
[1] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[2] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[3] Univ Miami, Coral Gables, FL 33124 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
522
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer
    Lumachi, Franco
    Santeufemia, Davide A.
    Fadda, Giovanni M.
    Tozzoli, Renato
    Chiara, Giordano B.
    Basso, Stefano M. M.
    MEDICINAL CHEMISTRY, 2016, 12 (03) : 261 - 267
  • [22] Adherence with adjuvant anastrozole therapy among women with early stage breast cancer.
    Partridge, A. H.
    LaFountain, A.
    Taylor, B.
    Asnis-Alibozek, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S186 - S186
  • [23] Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: A decision analysis
    Punglia, RS
    Kuntz, KM
    Winer, EP
    Weeks, JC
    Burstein, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5178 - 5187
  • [24] The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy
    Haoran Jiang
    Yu Dong
    Wei Zong
    Xiu-jie Zhang
    Hui Xu
    Feng Jin
    BMC Women's Health, 22
  • [25] The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy
    Jiang, Haoran
    Dong, Yu
    Zong, Wei
    Zhang, Xiu-jie
    Xu, Hui
    Jin, Feng
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [26] Current status of taxanes as adjuvant therapy for early-stage breast cancer
    Wolff, AC
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2005, 50 (05) : 227 - 229
  • [27] Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer
    Daniel Reinhorn
    Rinat Yerushalmi
    Assaf Moore
    Alexandra Desnoyers
    Ramy R. Saleh
    Eitan Amir
    Hadar Goldvaser
    Breast Cancer Research and Treatment, 2020, 182 : 259 - 266
  • [28] Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer
    Reinhorn, D. J.
    Amir, E.
    Yerushalmi, R.
    Goldvaser, H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer
    Reinhorn, Daniel
    Yerushalmi, Rinat
    Moore, Assaf
    Desnoyers, Alexandra
    Saleh, Ramy R.
    Amir, Eitan
    Goldvaser, Hadar
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 259 - 266
  • [30] Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer
    Hu, Xin
    Walker, Mark S.
    Stepanski, Edward
    Kaplan, Cameron M.
    Martin, Michelle Y.
    Vidal, Gregory A.
    Schwartzberg, Lee S.
    Graetz, Ilana
    JAMA NETWORK OPEN, 2022, 5 (08) : E2225485
12345